Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001504742 | SCV001709628 | likely benign | not provided | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV003994295 | SCV004812853 | uncertain significance | Steroid-resistant nephrotic syndrome | 2023-08-01 | criteria provided, single submitter | clinical testing | This sequence change is a synonymous (silent) variant in exon 5 of NPHS2 that has an uninformative predicted impact on splicing (SpliceAI). The highest population minor allele frequency in the population database gnomAD v2.1 is 0.01% (2/18,380 alleles) in the East Asian population, consistent with recessive disease. To our knowledge, this variant has not been previously reported in the relevant scientific literature. This variant has been observed with a pathogenic variant c.871C>T, p.(Arg291Trp) (ClinVar ID: 5369) in an individual with nephrotic syndrome (Melbourne Health Pathology). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, PM3_Supporting. |